General MedicationsORALGeneric
MEPROBAMATE
MEPROBAMATE
Standard Dose
600MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview MEPROBAMATE is listed in Drugs@FDA under application 085719 (ANDA).
Marketing status: Discontinued Active ingredient MEPROBAMATE Form and strength TABLET;ORAL - 600MG Sponsor WATSON LABS Submission history Latest submission status date: 1988-04-12 00:00:00.
Structured Monograph
Clinical summary
Approval overview MEPROBAMATE is listed in Drugs@FDA under application 085719 (ANDA). Marketing status: Discontinued Active ingredient MEPROBAMATE Form and strength TABLET;ORAL - 600MG Sponsor WATSON LABS Submission history Latest submission status date: 1988-04-12 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.